Polar Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $10.9M | Buy |
112,878
+23,000
| +26% | +$2.21M | 0.08% | 174 |
|
|
2020
Q2 | $11M | Sell |
89,878
-15,982
| -15% | -$1.95M | 0.09% | 169 |
|
|
2020
Q1 | $9.16M | Buy |
105,860
+45,860
| +76% | +$3.97M | 0.1% | 174 |
|
|
2019
Q4 | $6.45M | Sell |
60,000
-15,000
| -20% | -$1.61M | 0.06% | 223 |
|
|
2019
Q3 | $6.76M | Buy |
+75,000
| New | +$6.76M | 0.06% | 218 |
|
|
2018
Q4 | – | Sell |
-265,303
| Closed | -$32.6M | – | 277 |
|
|
2018
Q3 | $32.6M | Buy |
+265,303
| New | +$32.6M | 0.28% | 113 |
|
|
2017
Q2 | – | Sell |
-185,000
| Closed | -$8.01M | – | 254 |
|
|
2017
Q1 | $8.01M | Sell |
185,000
-412,256
| -69% | -$17.8M | 0.12% | 154 |
|
|
2016
Q4 | $23.1M | Buy |
597,256
+259,650
| +77% | +$10M | 0.37% | 85 |
|
|
2016
Q3 | $17.1M | Buy |
337,606
+39,570
| +13% | +$2M | 0.3% | 109 |
|
|
2016
Q2 | $13.5M | Buy |
298,036
+284,075
| +2,035% | +$12.9M | 0.26% | 111 |
|
|
2016
Q1 | $552K | Buy |
+13,961
| New | +$552K | 0.01% | 249 |
|
|
2013
Q3 | – | Sell |
-700,199
| Closed | -$9.37M | – | 261 |
|
|
2013
Q2 | $9.37M | Buy |
+700,199
| New | +$9.37M | 0.33% | 134 |
|